Citation: Ak. Aarsand et Sm. Carlsen, FOLATE ADMINISTRATION REDUCES CIRCULATING HOMOCYSTEINE LEVELS IN NIDDM PATIENTS ON LONG-TERM METFORMIN TREATMENT, Journal of internal medicine, 244(2), 1998, pp. 169-174
Citation: Sm. Carlsen et al., EVIDENCE FOR DISSOCIATION OF INSULIN-REDUCING AND WEIGHT-REDUCING EFFECTS OF METFORMIN IN NONDIABETIC MALE-PATIENTS WITH CORONARY HEART-DISEASE, Diabetes research and clinical practice, 39(1), 1998, pp. 47-54
Authors:
CARLSEN SM
FOLLING I
GRILL V
BJERVE KS
SCHNEEDE J
REFSUM H
Citation: Sm. Carlsen et al., METFORMIN INCREASES TOTAL SERUM HOMOCYSTEINE LEVELS IN NONDIABETIC MALE-PATIENTS WITH CORONARY HEART-DISEASE, Scandinavian journal of clinical & laboratory investigation, 57(6), 1997, pp. 521-527
Citation: I. Folling et al., METFORMIN DECREASES BODYWEIGHT AND INSULIN LEVELS BUT NOT CIRCULATINGLEPTIN LEVELS IN NONDIABETIC SUBJECTS, Diabetologia, 40, 1997, pp. 1240-1240
Authors:
CARLSEN SM
FOLLING I
GRILL V
BJERVE KS
SCHNEEDE J
REFSUM H
Citation: Sm. Carlsen et al., METFORMIN INCREASES TOTAL SERUM HOMOCYSTEINE LEVELS IN NONDIABETIC MALE-PATIENTS WITH CORONARY HEART-DISEASE, Diabetologia, 40, 1997, pp. 1823-1823
Authors:
CARLSEN SM
ROSSVOLL O
BJERVE KS
FOLLING I
Citation: Sm. Carlsen et al., SHOULD METFORMIN BE USED TO IMPROVE BLOOD LIPID PATTERN IN NONDIABETIC PATIENTS WITH CORONARY HEART-DISEASE - REPLY, Journal of internal medicine, 240(1), 1996, pp. 47-47
Authors:
CARLSEN SM
ROSSVOLL O
BJERVE KS
FOLLING I
Citation: Sm. Carlsen et al., METFORMIN IMPROVES BLOOD LIPID PATTERN IN NONDIABETIC PATIENTS WITH CORONARY HEART-DISEASE, Journal of internal medicine, 239(3), 1996, pp. 227-233